Lung cancer creates a huge economic burden for many  governments around the world. Efficient early detection methods can lead to improved outcomes and patient satisfaction during screening, diagnosis and monitoring.

We are currently developing Lung EpiCheck – a molecular diagnostic tool for lung cancer detection in blood samples based on our technology platform.